Please login to the form below

Not currently logged in
Email:
Password:

Rebiotix

This page shows the latest Rebiotix news and features for those working in and with pharma, biotech and healthcare.

Microbiome specialist Rebiotix chalks up C. diff trial success

Microbiome specialist Rebiotix chalks up C. diff trial success

Almost 79% of patients on Rebiotix's therapy had no recurrence over the course of the study, which compares favourably with a historical control rate of 52% says the company. ... Rebiotix's chief executive Lee Jones said the results suggest that a

Latest news

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics